Literature DB >> 21899241

Secondary ectasia due to forceps injury at childbirth: management with combined topography-guided partial PRK and collagen cross-linking (Athens Protocol) and subsequent phakic IOL implantation.

Anastasios John Kanellopoulos, Vasilios S Skouteris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21899241     DOI: 10.3928/1081597X-20110901-05

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


× No keyword cloud information.
  6 in total

Review 1.  Progress of corneal collagen cross-linking combined with refractive surgery.

Authors:  Na Li; Xiu-Jun Peng; Zheng-Jun Fan
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

2.  The management of cornea blindness from severe corneal scarring, with the Athens Protocol (transepithelial topography-guided PRK therapeutic remodeling, combined with same-day, collagen cross-linking).

Authors:  Anastasios John Kanellopoulos
Journal:  Clin Ophthalmol       Date:  2012-02-08

Review 3.  Keratoconus Treatment Algorithm.

Authors:  Konstantinos D Andreanos; Kate Hashemi; Myrsini Petrelli; Konstantinos Droutsas; Ilias Georgalas; George D Kymionis
Journal:  Ophthalmol Ther       Date:  2017-07-28

Review 4.  Obstetrical forceps-induced Descemet membrane tears.

Authors:  Rinky Agarwal; Nidhi Kalra Singh; Rajesh Sinha; Namrata Sharma
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

5.  Long-term safety and efficacy follow-up of prophylactic higher fluence collagen cross-linking in high myopic laser-assisted in situ keratomileusis.

Authors:  Anastasios John Kanellopoulos
Journal:  Clin Ophthalmol       Date:  2012-07-18

6.  Laboratory evaluation of selective in situ refractive cornea collagen shrinkage with continuous wave infrared laser combined with transepithelial collagen cross-linking: a novel refractive procedure.

Authors:  Anastasios John Kanellopoulos
Journal:  Clin Ophthalmol       Date:  2012-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.